Is Trigyn Techno. overvalued or undervalued?

As of 4 July 2025, Trigyn Techno. has moved from a fair to expensive valuation grade, indicating a shift in market perception. The company is currently considered overvalued based on its financial ratios, with a PE ratio of 22.15, a negative EV to EBIT of -10.90, and a ROE of only 1.60%. These figures suggest that the company's earnings and capital efficiency are not aligned with its market price.
In comparison to its peers, Trigyn's valuation stands out unfavorably; for instance, TCS has a PE ratio of 25.49 and a PEG ratio of 6.16, while Infosys shows a PE of 25.51 and a PEG of 14.59. The negative capital employed reflected in its EV to Capital Employed ratio of -0.41 further emphasizes the company's challenges. Additionally, despite a recent uptick in stock price, Trigyn's year-to-date return of -21.65% starkly contrasts with the Sensex's positive return of 6.77%, reinforcing the notion that the stock may be overvalued in the current market environment.